youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
ALC:NYSE
Alcon AG
$74.94
arrow_downward
-2.10%(-1.61) 1D
$74.94
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:06 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$74.24
High
$75.23
Low
$74.01
Mkt. cap
30.62B
Avg. vol.
1.83M
Volume
3.17M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$74.24
High
$75.23
Low
$74.01
Mkt. cap
30.62B
Avg. vol.
1.83M
Volume
3.17M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Dow Jones and S&P 500 Outlook: Stock Market News To Watch This Week
Exchange Rates UK
·
20 minutes ago
S&P 500 Slide Exposes Large Stock Moves Hidden Beneath The Index
Yahoo Finance
·
2 hours ago
Microsoft (MSFT) Makes the 10 Best Dow Stocks for 2027 List as Azure Growth Speeds Up
MarketWatch
·
4 hours ago
Corporate America’s profit numbers are just barely beating Wall Street’s expectations
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com